<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 31 Aug 2026 16:15:21 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Lifeward names interim CEO and CFO amid leadership change</title>
   <link>http://www.streetinsider.com/Management+Changes/Lifeward+names+interim+CEO+and+CFO+amid+leadership+change/27005885.html</link>
   <description>

&lt;p&gt;Lifeward Ltd. (Nasdaq: LFWD) announced the appointment of Josh Hexter as Interim Chief Executive Officer, effective September 1, 2026, and Rami Aviram as Chief Financial Officer, effective November 1, 2026, according to a company statement.&lt;/p&gt;

&lt;p&gt;Hexter succeeds Mark Grant, who is leaving Lifeward to pursue other opportunities. Grant will remain as a consultant through September 30, 2026 to assist with the transition. Hexter brings nearly three decades of life sciences experience, including roles as Chief Operating and Business Officer of Oramed Pharmaceuticals, Chief Business Officer of BrainsWay, and Executive Director of Corporate In-Licensing at BioLineRx. He also founded Biosensor Systems Design,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Lifeward+names+interim+CEO+and+CFO+amid+leadership+change/27005885.html</guid>
   <pubDate>Mon, 31 Aug 2026 16:15:21 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	  </item>
  <item>
   <title>Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Josh+Hexter+Interim+Chief+Executive+Officer+and+Rami+Aviram+Chief+Financial+Officer/27005861.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Experienced leadership team to build on established commercial platform and accelerate Lifeward’s next phase of growth with continuity of strategy&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT,&amp;#160;Israel, Aug.  31, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=OLJgUkJYlI_hxy1DPCApkCTMdtQvWeq8DFdrOV7wzpfL8-w6Rrop6U5FQlf6BFOEQJNZfOeb9NVz2Cj19eR93A==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Lifeward Ltd&lt;/a&gt;. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced the appointment of Josh Hexter as Interim Chief Executive Officer effective September 1, 2026 and Rami Aviram as Chief Financial Officer effective November 1, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Hexter succeeds Mark Grant, who has chosen to leave Lifeward to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Lifeward+Appoints+Josh+Hexter+Interim+Chief+Executive+Officer+and+Rami+Aviram+Chief+Financial+Officer/27005861.html</guid>
   <pubDate>Mon, 31 Aug 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	  </item>
  <item>
   <title>Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Lifeward+Appoints+Josh+Hexter+Interim+Chief+Executive+Officer+and+Rami+Aviram+Chief+Financial+Officer/27005861.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Experienced leadership team to build on established commercial platform and accelerate Lifeward’s next phase of growth with continuity of strategy&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;HUDSON, Mass. and YOKNEAM ILLIT,&amp;#160;Israel, Aug.  31, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=OLJgUkJYlI_hxy1DPCApkCTMdtQvWeq8DFdrOV7wzpfL8-w6Rrop6U5FQlf6BFOEQJNZfOeb9NVz2Cj19eR93A==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Lifeward Ltd&lt;/a&gt;. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced the appointment of Josh Hexter as Interim Chief Executive Officer effective September 1, 2026 and Rami Aviram as Chief Financial Officer effective November 1, 2026.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Hexter succeeds Mark Grant, who has chosen to leave Lifeward to</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Lifeward+Appoints+Josh+Hexter+Interim+Chief+Executive+Officer+and+Rami+Aviram+Chief+Financial+Officer/27005861.html</guid>
   <pubDate>Mon, 31 Aug 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	  </item>
  <item>
   <title>Form  4          Lifeward Ltd.             For: Aug 14  Filed by: Greenwald Yonason</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998250.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998250.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998250.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  4          Lifeward Ltd.             For: Aug 14  Filed by: Greenwald Yonason</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998250.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998250.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998250.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  3          Lifeward Ltd.             For: Aug 14  Filed by: Greenwald Yonason</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998102.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998102.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998102.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  3          Lifeward Ltd.             For: Aug 14  Filed by: Greenwald Yonason</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998102.html</link>
   <description>si-local-file:///var/storage/secattach/20260828/26998102.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14++Filed+by%3A+Greenwald+Yonason/26998102.html</guid>
   <pubDate>Fri, 28 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  4          Lifeward Ltd.             For: Aug 20  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969054.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969054.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969054.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  4          Lifeward Ltd.             For: Aug 20  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969054.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969054.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969054.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  3          Lifeward Ltd.             For: Aug 20  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969037.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969037.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  3          Lifeward Ltd.             For: Aug 20  Filed by: Gabay Avraham</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969037.html</link>
   <description>si-local-file:///var/storage/secattach/20260824/26969037.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+20++Filed+by%3A+Gabay+Avraham/26969037.html</guid>
   <pubDate>Mon, 24 Aug 2026 17:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>H.C. Wainwright Reiterates Buy Rating on Lifeward (LFWD)</title>
   <link>http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Lifeward+%28LFWD%29/26958413.html</link>
   <description>&lt;p&gt;H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $10.00 price target on Lifeward (NASDAQ: LFWD).&lt;/p&gt;&lt;p&gt;The analyst commented: &quot;Last week, Lifeward reported 2Q26 financial results. 2Q26 total revenues of $6.6M grew 16% YoY from $5.7M in 2Q25, and represent the strongest quarterly revenue performance since 4Q24, with US-based revenue grew 33% YoY to $4.1M. ReWalk Personal Exoskeleton sales rose 13% YoY to $2.5M, driven primarily by stronger demand in Europe and higher CMS revenue, while AlterG products and services grew 25% YoY to $4.1M on higher US unit shipments, service revenue, and average selling prices. Management expects revenue momentum</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/H.C.+Wainwright+Reiterates+Buy+Rating+on+Lifeward+%28LFWD%29/26958413.html</guid>
   <pubDate>Fri, 21 Aug 2026 07:04:04 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	  </item>
  <item>
   <title>Form  8-K        Lifeward Ltd.             For: Aug 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14/26956167.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26956167.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14/26956167.html</guid>
   <pubDate>Thu, 20 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Form  8-K        Lifeward Ltd.             For: Aug 14</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14/26956167.html</link>
   <description>si-local-file:///var/storage/secattach/20260820/26956167.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lifeward+Ltd.+++++++++++++For%3A+Aug+14/26956167.html</guid>
   <pubDate>Thu, 20 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension names Nadav Kidron to board, to chair new committee</title>
   <link>http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</link>
   <description>

&lt;p&gt;Nano Dimension Ltd. (NASDAQ: NNDM) has appointed Nadav Kidron to its board of directors, where he will chair a newly formed Strategy and Capital Allocation Committee, according to a company statement.&lt;/p&gt;

&lt;p&gt;The committee, part of an ongoing strategic review led by board Chairman Phillip Borenstein, will evaluate capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, and other strategic opportunities.&lt;/p&gt;

&lt;p&gt;Kidron is the president and chief executive officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), which is described as a significant shareholder of Nano Dimension. He also serves on the boards of Alpha Tau Medical Ltd. (NASDAQ: DRTS)</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Nano+Dimension+names+Nadav+Kidron+to+board%2C+to+chair+new+committee/26935122.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:01:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</link>
   <description>
&lt;p&gt;WALTHAM, Mass., Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).&lt;/p&gt;  &lt;p&gt;As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</link>
   <description>
&lt;p&gt;WALTHAM, Mass., Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).&lt;/p&gt;  &lt;p&gt;As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
  <item>
   <title>Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee</title>
   <link>http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</link>
   <description>
&lt;p&gt;WALTHAM, Mass., Aug.  17, 2026  (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).&lt;/p&gt;  &lt;p&gt;As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders, monetization of non-core assets, strategic opportunities and other initiatives intended to maximize long-term shareholder value. Mr. Kidron will chair this committee and work with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Nano+Dimension+Appoints+Nadav+Kidron+to+Board+of+Directors+to+Chair+Strategy+and+Capital+Allocation+Committee/26935076.html</guid>
   <pubDate>Mon, 17 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DRTS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LFWD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NNDM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.05713056</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13805217</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49911888</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.56010000</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ORMP</category>
   	  </item>
 </channel>
</rss>
